These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37330413)

  • 1. Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review.
    Crupi E; de Padua TC; Marandino L; Raggi D; Dyrskjøt L; Spiess PE; Sonpavde GP; Kamat AM; Necchi A
    Eur Urol Oncol; 2024 Feb; 7(1):44-52. PubMed ID: 37330413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
    Szabados B; Kockx M; Assaf ZJ; van Dam PJ; Rodriguez-Vida A; Duran I; Crabb SJ; Van Der Heijden MS; Pous AF; Gravis G; Herranz UA; Protheroe A; Ravaud A; Maillet D; Mendez MJ; Suarez C; Linch M; Prendergast A; Tyson C; Stanoeva D; Daelemans S; Rombouts M; Mariathasan S; Tea JS; Mousa K; Sharma S; Aleshin A; Banchereau R; Castellano D; Powles T
    Eur Urol; 2022 Aug; 82(2):212-222. PubMed ID: 35577646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma.
    Powles T; Assaf ZJ; Degaonkar V; Grivas P; Hussain M; Oudard S; Gschwend JE; Albers P; Castellano D; Nishiyama H; Daneshmand S; Sharma S; Sethi H; Aleshin A; Shi Y; Davarpanah N; Carter C; Bellmunt J; Mariathasan S
    Eur Urol; 2024 Feb; 85(2):114-122. PubMed ID: 37500339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Tumor-informed Circulating Tumor DNA Status Predicts Disease Upstaging and Poor Prognosis for Patients Undergoing Radical Cystectomy.
    Ben-David R; Tillu N; Cumarasamy S; Alerasool P; Rich JM; Kaufmann B; Elkun Y; Attalla K; Mehrazin R; Wiklund P; Sfakianos JP
    Eur Urol Oncol; 2024 Oct; 7(5):1105-1112. PubMed ID: 38521660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
    Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
    JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Agnostic Circulating Tumor DNA Testing for Monitoring Muscle-Invasive Bladder Cancer.
    Carrasco R; Ingelmo-Torres M; Trullas R; Roldán FL; Rodríguez-Carunchio L; Juez L; Sureda J; Alcaraz A; Mengual L; Izquierdo L
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review.
    de Kruijff IE; Beije N; Martens JWM; de Wit R; Boormans JL; Sleijfer S
    Eur Urol Oncol; 2021 Apr; 4(2):204-214. PubMed ID: 32059957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
    Powles T; Assaf ZJ; Davarpanah N; Banchereau R; Szabados BE; Yuen KC; Grivas P; Hussain M; Oudard S; Gschwend JE; Albers P; Castellano D; Nishiyama H; Daneshmand S; Sharma S; Zimmermann BG; Sethi H; Aleshin A; Perdicchio M; Zhang J; Shames DS; Degaonkar V; Shen X; Carter C; Bais C; Bellmunt J; Mariathasan S
    Nature; 2021 Jul; 595(7867):432-437. PubMed ID: 34135506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumour DNA and Its Prognostic Role in Management of Muscle Invasive Bladder Cancer: A Narrative Review of the Literature.
    Kapriniotis K; Tzelves L; Lazarou L; Mitsogianni M; Mitsogiannis I
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.
    Carrasco R; Ingelmo-Torres M; Gómez A; Trullas R; Roldán FL; Ajami T; Moreno D; Rodríguez-Carunchio L; Alcaraz A; Izquierdo L; Mengual L
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.
    Pietzak EJ; Zabor EC; Bagrodia A; Armenia J; Hu W; Zehir A; Funt S; Audenet F; Barron D; Maamouri N; Li Q; Teo MY; Arcila ME; Berger MF; Schultz N; Dalbagni G; Herr HW; Bajorin DF; Rosenberg JE; Al-Ahmadie H; Bochner BH; Solit DB; Iyer G
    Eur Urol; 2019 Feb; 75(2):231-239. PubMed ID: 30290956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer.
    Sfakianos JP; Basu A; Laliotis G; Cumarasamy S; Rich JM; Kommalapati A; Glover M; Mahmood T; Tillu N; Hoimes CJ; Selig G; Kollipara R; Stewart TF; Rivero-Hinojosa S; Dutta P; Calhoun M; Sharma S; Malhotra M; ElNaggar AC; Liu MC; Ferguson JE; Diniz M; Mehrazin R; Wiklund P; Tan A; Shah S; Galsky MD
    Eur Urol Oncol; 2024 Jul; ():. PubMed ID: 39013741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis.
    Liu H; Chen J; Huang Y; Zhang Y; Ni Y; Xu N; Zhao F; Tang Y; Liu H; Sun G; Shen P; Liu Z; Huang J; Liao B; Zeng H
    Int J Surg; 2024 Jun; 110(6):3923-3936. PubMed ID: 38573063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
    Radovich M; Jiang G; Hancock BA; Chitambar C; Nanda R; Falkson C; Lynce FC; Gallagher C; Isaacs C; Blaya M; Paplomata E; Walling R; Daily K; Mahtani R; Thompson MA; Graham R; Cooper ME; Pavlick DC; Albacker LA; Gregg J; Solzak JP; Chen YH; Bales CL; Cantor E; Shen F; Storniolo AMV; Badve S; Ballinger TJ; Chang CL; Zhong Y; Savran C; Miller KD; Schneider BP
    JAMA Oncol; 2020 Sep; 6(9):1410-1415. PubMed ID: 32644110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
    Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
    ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature.
    Green EA; Li R; Albiges L; Choueiri TK; Freedman M; Pal S; Dyrskjøt L; Kamat AM
    Eur Urol Oncol; 2021 Dec; 4(6):893-903. PubMed ID: 33975782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.
    Lu YT; Plets M; Morrison G; Cunha AT; Cen SY; Rhie SK; Siegmund KD; Daneshmand S; Quinn DI; Meeks JJ; Lerner SP; Petrylak DP; McConkey D; Flaig TW; Thompson IM; Goldkorn A
    Eur Urol Oncol; 2023 Oct; 6(5):516-524. PubMed ID: 37087309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery.
    Jackson-Spence F; Toms C; O'Mahony LF; Choy J; Flanders L; Szabados B; Powles T
    Future Oncol; 2023 Mar; 19(7):509-515. PubMed ID: 37082935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis.
    Boutaleb I; Mjaess G; Roumeguère T
    Fr J Urol; 2024 Sep; 34(9):102704. PubMed ID: 39059767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
    Tan MP; Attard G; Huddart RA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30158468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.